BSE Live
Jun 02, 16:01Prev. Close
932.15
Open Price
932.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jun 02, 15:59Prev. Close
932.45
Open Price
936.00
Bid Price (Qty.)
922.25 (8)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Gland Pharma (in Rs. Cr.) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 16.47 | 16.43 | 16.36 | 15.50 | 15.50 | |
Total Share Capital | 16.47 | 16.43 | 16.36 | 15.50 | 15.50 | |
Reserves and Surplus | 7,936.83 | 7,141.72 | 5,886.93 | 3,630.74 | 2,846.62 | |
Total Reserves and Surplus | 7,936.83 | 7,141.72 | 5,886.93 | 3,630.74 | 2,846.62 | |
Total Shareholders Funds | 7,953.30 | 7,158.15 | 5,903.29 | 3,646.24 | 2,862.11 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 3.26 | 3.82 | 3.93 | 4.07 | 4.96 | |
Deferred Tax Liabilities [Net] | 84.20 | 87.76 | 73.88 | 74.05 | 107.63 | |
Other Long Term Liabilities | 2.22 | 2.39 | 2.50 | 2.66 | 15.20 | |
Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 89.68 | 93.98 | 80.31 | 80.78 | 127.79 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.56 | 0.11 | 0.00 | 0.00 | 0.00 | |
Trade Payables | 589.42 | 462.76 | 400.66 | 249.09 | 446.20 | |
Other Current Liabilities | 108.90 | 94.29 | 86.67 | 92.45 | 83.60 | |
Short Term Provisions | 31.32 | 24.77 | 25.13 | 17.48 | 2.88 | |
Total Current Liabilities | 730.20 | 581.94 | 512.46 | 359.02 | 532.68 | |
Total Capital And Liabilities | 8,773.18 | 7,834.14 | 6,496.06 | 4,086.04 | 3,522.58 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 1,747.38 | 1,499.66 | 954.23 | 968.10 | 928.74 | |
Intangible Assets | 0.00 | 2.54 | 0.00 | 0.00 | 0.00 | |
Capital Work-In-Progress | 0.00 | 180.75 | 337.81 | 188.47 | 123.16 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 1,747.38 | 1,692.94 | 1,292.04 | 1,156.57 | 1,051.91 | |
Non-Current Investments | 8.16 | 8.16 | 0.55 | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 129.31 | 288.60 | 80.40 | 83.18 | 113.22 | |
Total Non-Current Assets | 1,884.84 | 1,989.70 | 1,372.99 | 1,239.75 | 1,165.13 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 154.87 | 0.00 | 0.00 | 0.00 | |
Inventories | 1,945.30 | 1,185.67 | 1,275.17 | 756.28 | 911.88 | |
Trade Receivables | 862.84 | 1,198.78 | 670.97 | 601.79 | 506.10 | |
Cash And Cash Equivalents | 3,767.00 | 3,085.80 | 3,005.20 | 1,325.19 | 753.35 | |
Short Term Loans And Advances | 0.14 | 0.47 | 0.25 | 0.50 | 0.28 | |
OtherCurrentAssets | 313.06 | 218.85 | 171.47 | 162.54 | 185.86 | |
Total Current Assets | 6,888.34 | 5,844.44 | 5,123.07 | 2,846.29 | 2,357.46 | |
Total Assets | 8,773.18 | 7,834.14 | 6,496.06 | 4,086.04 | 3,522.58 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 124.53 | 219.23 | 134.54 | 171.60 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 162.85 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 1,551.47 | 1,687.83 | 724.98 | 958.28 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | -- | 3,514.50 | 2,902.06 | 2,163.51 | 1,651.86 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
18.05.2023
Gland Standalone March 2023 Net Sales at Rs 785.42 crore, down 28.79% Y-o-Y
18.05.2023
Gland Consolidated March 2023 Net Sales at Rs 785.01 crore, down 28.83% Y-o-Y
23.01.2023
Gland Standalone December 2022 Net Sales at Rs 925.90 crore, down 12.92% Y-o-Y
23.01.2023
Gland Consolidated December 2022 Net Sales at Rs 938.29 crore, down 11.76% Y-o-Y